Group 1 - Tencent Holdings (00700.HK) reduced its stake in Crystal Technology Holdings (02228.HK) from 6.47% to 5.93% [1] - Goldman Sachs raised the target price for Li Auto (02015.HK) to HKD 138 and increased earnings estimates for 2025 to 2027 [1] - UBS reduced its stake in Midea Group (00300.HK) from 5.05% to 4.95% on May 28 [1] Group 2 - Red Star Macalline (01528.HK) approved the draft restructuring plan for Red Star Macalline Holdings Group [1] - Genscript Biotech (01672.HK) achieved all endpoints in the Phase III trial of its first-in-class oral FASN inhibitor, ASC40, for acne [1] - Yaoshi Bang (09885.HK) signed a strategic cooperation and business deployment agreement with Yujian Technology to explore the application of collaborative robots and related AI products in drug development [1] Group 3 - NIO Inc. (09866.HK) reported Q1 2025 revenue of CNY 12.035 billion, up from CNY 9.91 billion in the same period last year; Q1 net loss was CNY 6.89 billion, compared to a net loss of CNY 5.258 billion in the previous year; the company expects delivery numbers for the second quarter to be between 72,000 and 75,000 vehicles [1]
整理:每日港股市场要闻速递(6月4日 周三)